FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2541920404> ?p ?o ?g. }

• W2541920404 endingPage "382" @default.
• W2541920404 startingPage "375" @default.
• W2541920404 abstract "Approximately 50% of recurrences after standard-dose chemoradiation for locally advanced esophageal cancer occur within the gross tumor volume (GTV). In this prospective phase I/II clinical trial, we explored the use of a simultaneous integrated boost (SIB) dose to the GTV.Forty-four patients with unresectable esophageal cancer received chemoradiation with an SIB of 58.8 to 63 Gy to the GTV and 50.4 Gy to the planning target volume, all in 28 fractions, with 5 weeks of concurrent docetaxel and fluorouracil or capecitabine. The end points were maximum tolerated dose, time to local failure, and clinical response.Excluding those with less than 6 months of follow-up, 38 patients were evaluated at the time of analysis. The median age was 65 years (range 37-84). Most patients (71%) were men; 84% had T3 disease, 37% had N1 disease, 26% had N2 disease, 13% had M1 disease, and 50% had adenocarcinoma. The maximum tolerated SIB dose was 63 Gy. None experienced Common Terminology Criteria for Adverse Events grade 4 or 5 toxicity. At a median follow-up time of 13.3 months (range 1.2-36.2), 11 (29%) had local failure (median time to local failure 2.5 months [range 1.5-23.9]). A comparison with 97 similar patients who received 50.4 Gy without an SIB showed that the SIB reduced the local failure rate for patients with node-positive disease (13% versus 56%, p = 0.04), adenocarcinoma (26% versus 59%, p = 0.02), or stage III-IV disease (29% versus 55%, p = 0.04).SIB intensity-modulated radiation therapy to gross primary disease may improve local control for patients with unresectable locally advanced esophageal cancer, especially those with adenocarcinoma." @default.
• W2541920404 created "2016-11-04" @default.
• W2541920404 creator A5008781374 @default.
• W2541920404 creator A5010129367 @default.
• W2541920404 creator A5010974431 @default.
• W2541920404 creator A5016123864 @default.
• W2541920404 creator A5027873506 @default.
• W2541920404 creator A5033960859 @default.
• W2541920404 creator A5036956658 @default.
• W2541920404 creator A5044064524 @default.
• W2541920404 creator A5055965589 @default.
• W2541920404 creator A5057774493 @default.
• W2541920404 creator A5060222943 @default.
• W2541920404 creator A5069486509 @default.
• W2541920404 creator A5071173748 @default.
• W2541920404 creator A5074288744 @default.
• W2541920404 creator A5076621000 @default.
• W2541920404 creator A5085763839 @default.
• W2541920404 creator A5087201995 @default.
• W2541920404 date "2017-02-01" @default.
• W2541920404 modified "2023-10-13" @default.
• W2541920404 title "Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial" @default.
• W2541920404 cites W1922694287 @default.
• W2541920404 cites W2025371525 @default.
• W2541920404 cites W2046980134 @default.
• W2541920404 cites W2051618879 @default.
• W2541920404 cites W2061162807 @default.
• W2541920404 cites W2127996441 @default.
• W2541920404 cites W2154444715 @default.
• W2541920404 cites W2166365730 @default.
• W2541920404 cites W2302069842 @default.
• W2541920404 cites W2460890166 @default.
• W2541920404 cites W4236554935 @default.
• W2541920404 doi "https://doi.org/10.1016/j.jtho.2016.10.013" @default.
• W2541920404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27794500" @default.
• W2541920404 hasPublicationYear "2017" @default.
• W2541920404 type Work @default.
• W2541920404 sameAs 2541920404 @default.
• W2541920404 citedByCount "54" @default.
• W2541920404 countsByYear W25419204042017 @default.
• W2541920404 countsByYear W25419204042018 @default.
• W2541920404 countsByYear W25419204042019 @default.
• W2541920404 countsByYear W25419204042020 @default.
• W2541920404 countsByYear W25419204042021 @default.
• W2541920404 countsByYear W25419204042022 @default.
• W2541920404 countsByYear W25419204042023 @default.
• W2541920404 crossrefType "journal-article" @default.
• W2541920404 hasAuthorship W2541920404A5008781374 @default.
• W2541920404 hasAuthorship W2541920404A5010129367 @default.
• W2541920404 hasAuthorship W2541920404A5010974431 @default.
• W2541920404 hasAuthorship W2541920404A5016123864 @default.
• W2541920404 hasAuthorship W2541920404A5027873506 @default.
• W2541920404 hasAuthorship W2541920404A5033960859 @default.
• W2541920404 hasAuthorship W2541920404A5036956658 @default.
• W2541920404 hasAuthorship W2541920404A5044064524 @default.
• W2541920404 hasAuthorship W2541920404A5055965589 @default.
• W2541920404 hasAuthorship W2541920404A5057774493 @default.
• W2541920404 hasAuthorship W2541920404A5060222943 @default.
• W2541920404 hasAuthorship W2541920404A5069486509 @default.
• W2541920404 hasAuthorship W2541920404A5071173748 @default.
• W2541920404 hasAuthorship W2541920404A5074288744 @default.
• W2541920404 hasAuthorship W2541920404A5076621000 @default.
• W2541920404 hasAuthorship W2541920404A5085763839 @default.
• W2541920404 hasAuthorship W2541920404A5087201995 @default.
• W2541920404 hasBestOaLocation W25419204041 @default.
• W2541920404 hasConcept C121608353 @default.
• W2541920404 hasConcept C126322002 @default.
• W2541920404 hasConcept C141071460 @default.
• W2541920404 hasConcept C146357865 @default.
• W2541920404 hasConcept C151730666 @default.
• W2541920404 hasConcept C188816634 @default.
• W2541920404 hasConcept C197934379 @default.
• W2541920404 hasConcept C2776694085 @default.
• W2541920404 hasConcept C2777793932 @default.
• W2541920404 hasConcept C2777909004 @default.
• W2541920404 hasConcept C2778822529 @default.
• W2541920404 hasConcept C2779742542 @default.
• W2541920404 hasConcept C2781182431 @default.
• W2541920404 hasConcept C2781190966 @default.
• W2541920404 hasConcept C526805850 @default.
• W2541920404 hasConcept C535046627 @default.
• W2541920404 hasConcept C61943457 @default.
• W2541920404 hasConcept C71924100 @default.
• W2541920404 hasConcept C86803240 @default.
• W2541920404 hasConceptScore W2541920404C121608353 @default.
• W2541920404 hasConceptScore W2541920404C126322002 @default.
• W2541920404 hasConceptScore W2541920404C141071460 @default.
• W2541920404 hasConceptScore W2541920404C146357865 @default.
• W2541920404 hasConceptScore W2541920404C151730666 @default.
• W2541920404 hasConceptScore W2541920404C188816634 @default.
• W2541920404 hasConceptScore W2541920404C197934379 @default.
• W2541920404 hasConceptScore W2541920404C2776694085 @default.
• W2541920404 hasConceptScore W2541920404C2777793932 @default.
• W2541920404 hasConceptScore W2541920404C2777909004 @default.
• W2541920404 hasConceptScore W2541920404C2778822529 @default.
• W2541920404 hasConceptScore W2541920404C2779742542 @default.
• W2541920404 hasConceptScore W2541920404C2781182431 @default.
• W2541920404 hasConceptScore W2541920404C2781190966 @default.

• next